When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant Sciences files application in Europe for relugolix combo tablet
Myovant Sciences Ltd.
Myovant Sciences (NYSE:MYOV) has submitted a marketing application in Europe seeking approval to use a combination tablet formulation of relugolix (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) to treat women with moderate-to-severe symptoms associated with uterine fibroids (heavy menstrual bleeding and pain).
More news on: Myovant Sciences Ltd., Healthcare stocks news, Stocks on the move,